3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein Degradation

被引:101
|
作者
Testa, Andrea [1 ]
Lucas, Xavier [1 ]
Castro, Guilherme, V [1 ]
Chan, Kwok-Ho [1 ]
Wright, Jane E. [1 ]
Runcie, Andrew C. [1 ]
Gadd, Morgan S. [1 ,4 ]
Harrison, William T. A. [2 ]
Ko, Eun-Jung [3 ]
Fletcher, Daniel [3 ]
Ciulli, Alessio [1 ]
机构
[1] Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, James Black Ctr, Dow St, Dundee DD1 5EH, Scotland
[2] Univ Aberdeen, Dept Chem, Aberdeen AB24 3UE, Scotland
[3] Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit,James Black Ctr, Dow St, Dundee DD1 5EH, Scotland
[4] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England
基金
英国惠康基金; 英国生物技术与生命科学研究理事会; 欧洲研究理事会; 欧盟地平线“2020”;
关键词
SMALL-MOLECULE PROTACS; COLLAGEN TRIPLE-HELIX; MEDICINAL CHEMISTRY; STRUCTURAL BASIS; ACID-ANALOGS; STABILITY; PROLINE; HYDROXYPROLINE; INHIBITORS; COMPLEX;
D O I
10.1021/jacs.8b05807
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Hydroxylation and fluorination of proline alters the pyrrolidine ring pucker and the trans:cis amide bond ratio in a stereochemistry-dependent fashion, affecting molecular recognition of proline-containing molecules by biological systems. While hydroxyprolines and fluoroprolines are common motifs in medicinal and biological chemistry, the synthesis and molecular properties of prolines containing both modifications, i.e., fluoro-hydroxyprolines, have not been described. Here we present a practical and facile synthesis of all four diastereoisomers of 3-fluoro-4-hydroxyprolines (F-Hyps), starting from readily available 4-oxo-L-proline derivatives. Small-molecule X-ray crystallography; NMR spectroscopy, and quantum mechanical calculations are consistent with fluorination at C-3 having negligible effects on the hydrogen bond donor capacity of the C-4 hydroxyl, but inverting the natural preference of Hyp from C-4-exo to C-4-endo pucker. In spite of this, F-Hyps still bind to the von Hippel-Lindau (VHL) E3 ligase, which naturally recognizes C-4-exo Hyp in a stereoselective fashion. Cocrystal structures and electrostatic potential calculations support and rationalize the observed preferential recognition for (3R,4S)-F-Hyp over the corresponding (3S,4S) epimer by VHL. We show that (3R,4S)-F-Hyp provides bioisosteric Hyp substitution in both hypoxia-inducible factor 1 alpha (HIF-1 alpha) substrate peptides and peptidomimetic ligands that form part of PROTAC (proteolysis targeting chimera) conjugates for targeted protein degradation. Despite a weakened affinity, Hyp substitution with (3S,4S)-F-Hyp within the PROTAC MZ1 led to Brd4-selective cellular degradation at concentrations > 100-fold lower than the binary K-d for VHL. We anticipate that the disclosed chemistry of 3-fluoro-4-hydroxyprolines and their application as VHL ligands for targeted protein degradation will be of wide interest to medicinal organic chemists, chemical biologists, and drug discoverers alike.
引用
收藏
页码:9299 / 9313
页数:15
相关论文
共 50 条
  • [21] Recognition and reprogramming of E3 ubiquitin ligase surfaces by α-helical peptides
    Tokareva, Olena S.
    Li, Kunhua
    Travaline, Tara L.
    Thomson, Ty M.
    Swiecicki, Jean-Marie
    Moussa, Mahmoud
    Ramirez, Jessica D.
    Litchman, Sean
    Verdine, Gregory L.
    Mcgee, John H.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [22] Utilizing natural products as new E3 ligase ligands for targeted protein degradation
    GONG Yanan
    WANG Saiqi
    CHEN XiaoBing
    YU Bin
    Chinese Journal of Natural Medicines, 2023, 21 (12) : 881 - 883
  • [23] Utilizing natural products as new E3 ligase ligands for targeted protein degradation
    Gong, Yanan
    Wang, Saiqi
    Chen, Xiao-Bing
    Yu, Bin
    CHINESE JOURNAL OF NATURAL MEDICINES, 2023, 21 (12) : 881 - 883
  • [24] Discovery of cancer-specific E3 ligase ligands for targeted protein degradation
    Wang, Zhaofu
    Zhang, Lynette
    Chang, Zhen
    Zhao, Mengxi
    Li, Guobin
    Qin, Fang
    Ma, Shichao
    Li, Yunfeng
    Zhang, Zhongguo
    Wang, Xinghao
    Kong, Ying
    Lou, Shidi
    Chen, Sheng
    Liu, Lanzhen
    Xu, Shuaijie
    Zhang, Hailong
    CANCER RESEARCH, 2023, 83 (07)
  • [25] Ubiquibodies: Engineered E3 Ubiquitin Ligases for Targeted Degradation
    Stephens, Erin A.
    Portnoff, Alyse D.
    Baltz, Morgan R.
    Varner, Jeffrey D.
    DeLisa, Matthew P.
    PROTEIN SCIENCE, 2014, 23 : 155 - 155
  • [26] Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase
    Xu, K
    Belunis, C
    Chu, W
    Weber, D
    Podlaski, F
    Huang, KS
    Reed, SI
    Vassilev, LT
    BIOCHEMICAL JOURNAL, 2003, 371 (03) : 957 - 964
  • [27] The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara
    Yu, Jian
    Lan, Jianping
    Zhu, Yuanyuan
    Li, Xiaoxiao
    Lai, Xiaoyu
    Xue, Yu
    Jin, Changjiang
    Huang, He
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 367 (04) : 805 - 812
  • [28] α4 Phosphoprotein Interacts With EDD E3 Ubiquitin Ligase and Poly(A)-Binding Protein
    McDonald, William J.
    Sangster, Shirley M.
    Moffat, Lori D.
    Henderson, Michelle J.
    Too, Catherine K. L.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 110 (05) : 1123 - 1129
  • [29] A new, therapeutically actionable target for the VHL E3 ubiquitin ligase in renal cell carcinoma
    Hasanov, Elshad
    Chen, Guang
    Chowdhury, Pratim
    Weldon, Justin
    Jonasch, Eric
    Sen, Subrata
    Walker, Cheryl Lyn
    Dere, Ruhee
    CANCER RESEARCH, 2016, 76
  • [30] Expanding Chemical Libraries of E3 Ubiquitin Ligases to Unlock Targeted Protein Degradation
    Jalagadugula, G.
    Russell, A.
    Wallace, K.
    Pedroza, J.
    Haseeb, A.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 1197 - 1198